B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.

Front Immunol · 2020 · PMC7868381 · PMID 33569063

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This showed that 19% of patients developed autoantibodies on-treatment and a trend of association with onset of irAE which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.